Radioactive Microspheres for Selective Internal Radiation Therapy of Hepatocellular Carcinoma

被引:3
|
作者
Zhou, Yi [1 ]
Gao, Yun [1 ]
Duan, Guangxin [1 ]
Wen, Ling [2 ]
Shan, Shanshan [1 ]
Wu, Shuwang [1 ]
Zeng, Jianfeng [1 ]
Gao, Mingyuan [1 ]
机构
[1] Soochow Univ, Collaborat Innovat Ctr Radiol Med Jiangsu Higher E, Ctr Mol Imaging & Nucl Med, Sch Radiol & Interdisciplinary Sci, Suzhou 215123, Peoples R China
[2] Soochow Univ, Dept Radiol, Affiliated Hosp 1, Suzhou 215000, Peoples R China
来源
ADVANCED NANOBIOMED RESEARCH | 2023年 / 3卷 / 06期
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; radioactive microspheres; selective internal radiation therapy; POLY(L-LACTIC ACID) MICROSPHERES; TARGETED RADIONUCLIDE THERAPY; COLORECTAL LIVER METASTASES; IN-VIVO; Y-90; MICROSPHERES; ALBUMIN MICROSPHERES; GLASS MICROSPHERES; ACETYLACETONATE MICROSPHERES; GELATIN MICROSPHERES; NEUTRON-ACTIVATION;
D O I
10.1002/anbr.202200166
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Selective internal radiation therapy (SIRT) as one of the radiotherapeutic techniques has been widely used in the treatment of primary and metastatic liver cancer, for better avoiding radiation damage to normal tissues from external exposure. The radioactive microspheres used in SIRT should meet some special requirements closely associated with the type of radionuclides and the size and the property of the microsphere. This review focuses on the radioactive microspheres to elaborate the current challenges in the related fields, including simplification of the preparation of microspheres formed by different materials, visualization of the biodistribution of microspheres, and the suitability of different types of microspheres for repeated treatment. In this context, the major characteristics of three kinds of commercialized radioactive microspheres are compared, the advances in the radioactive microspheres achieved in recent years are summarized, and the future prospects of radioactive microspheres are discussed.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Outcomes and Predictors of Toxicity after selective internal radiation Therapy Using Yttrium-90 resin Microspheres for Unresectable hepatocellular carcinoma
    Gabrielson, Andrew
    Miller, Akemi
    Banovac, Filip
    Kim, Alexander
    He, Aiwu Ruth
    Unger, Keith
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [22] COST-UTILITY ANALYIS OF SELECTIVE INTERNAL RADIATION THERAPY (SIRT) WITH Y-90 RESIN MICROSPHERES IN HEPATOCELLULAR CARCINOMA (HCC)
    Muszbek, N.
    Remak, E.
    Evans, R.
    Brennan, V
    Colaone, F.
    Shergill, S.
    VALUE IN HEALTH, 2019, 22 : S452 - S452
  • [23] Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis
    Edeline, Julien
    Crouzet, Laurence
    Campillo-Gimenez, Boris
    Rolland, Yan
    Pracht, Marc
    Guillygomarc'h, Anne
    Boudjema, Karim
    Lenoir, Laurence
    Adhoute, Xavier
    Rohou, Tanguy
    Boucher, Eveline
    Clement, Bruno
    Blanc, Jean-Frederic
    Garin, Etienne
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (04) : 635 - 643
  • [24] Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
    Ricke, Jens
    Klumpen, Heinz Josef
    Amthauer, Holger
    Bargellini, Irene
    Bartenstein, Peter
    de Toni, Enrico N.
    Gasbarrini, Antonio
    Pech, Maciej
    Peck-Radosavljevic, Markus
    Popovic, Peter
    Rosmorduc, Olivier
    Schott, Eckart
    Seidensticker, Max
    Verslype, Chris
    Sangro, Bruno
    Malfertheiner, Peter
    JOURNAL OF HEPATOLOGY, 2019, 71 (06) : 1164 - 1174
  • [25] A microscopic model of the dose distribution in hepatocellular carcinoma after selective internal radiation therapy
    Cutri, Elena
    Morel-Corlu, Ewan
    Rolland, Yan
    Saint-Jalmes, Herve
    Eliat, Pierre-Antoine
    Garin, Etienne
    Bezy-Wendling, Johanne
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2024, 122
  • [26] Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis
    Julien Edeline
    Laurence Crouzet
    Boris Campillo-Gimenez
    Yan Rolland
    Marc Pracht
    Anne Guillygomarc’h
    Karim Boudjema
    Laurence Lenoir
    Xavier Adhoute
    Tanguy Rohou
    Eveline Boucher
    Bruno Clément
    Jean-Frédéric Blanc
    Etienne Garin
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 635 - 643
  • [27] A Simple Prognostic Scoring System for Hepatocellular Carcinoma Treated with Selective Internal Radiation Therapy
    op den Winkel, Mark
    Nagel, Dorothea
    de la Torre Alaez, Manuel A.
    Hempe, Stephanie
    De Toni, Enrico N.
    Paprottka, Karolin J.
    op den Winkel, Philip
    Stecher, Stephanie-Susanne
    Bourhis, Helene
    Gerbes, Alexander L.
    Ricke, Jens
    Sangro, Bruno
    Kolligs, Frank T.
    DIGESTIVE DISEASES, 2022, 40 (03) : 322 - 334
  • [28] Evidence-based integration of selective internal radiation therapy into hepatocellular carcinoma management
    Sangro, Bruno
    FUTURE ONCOLOGY, 2014, 10 (15) : 7 - 11
  • [29] Valproate as a novel radiosensitizer in selective internal radiation therapy (SIRT) for unresectable hepatocellular carcinoma
    Chin, Kenneth
    Udumala, Sunil Kumar
    Kannadorai, Ravi Kumar
    Yu, Sidney Wing Kwong
    Chow, Pierce K. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [30] Antitumor efficacy of selective internal radiation therapy (SIRT) for patients with hepatocellular carcinoma (HCC)
    Sangro, Bruno
    Boan, Jose
    Rodriguez, Javier
    Bilbao, Ignacio
    Martinez-Cuesta, Antonio
    Benito, Alberto
    Gil, Belen
    Inarrairaegui, Mercedes
    Herrero, Ignacio
    Quiroga, Jorge
    Prieto, Jesus
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A170 - A170